These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8540595)

  • 1. Hypothalamic-pituitary-adrenal axis activity in panic disorder: prediction of long-term outcome by pretreatment cortisol levels.
    Abelson JL; Curtis GC
    Am J Psychiatry; 1996 Jan; 153(1):69-73. PubMed ID: 8540595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamic-pituitary-adrenal axis activity in panic disorder: effects of alprazolam on 24 h secretion of adrenocorticotropin and cortisol.
    Abelson JL; Curtis GC; Cameron OG
    J Psychiatr Res; 1996; 30(2):79-93. PubMed ID: 8816303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic-pituitary-adrenal axis activity in panic disorder. 24-hour secretion of corticotropin and cortisol.
    Abelson JL; Curtis GC
    Arch Gen Psychiatry; 1996 Apr; 53(4):323-31. PubMed ID: 8634010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPA axis activity in patients with panic disorder: review and synthesis of four studies.
    Abelson JL; Khan S; Liberzon I; Young EA
    Depress Anxiety; 2007; 24(1):66-76. PubMed ID: 16845643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive modulation of the endocrine stress response to a pharmacological challenge in normal and panic disorder subjects.
    Abelson JL; Liberzon I; Young EA; Khan S
    Arch Gen Psychiatry; 2005 Jun; 62(6):668-75. PubMed ID: 15939844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenocorticotropic hormone and cortisol responses to corticotropin-releasing hormone: changes in panic disorder and effects of alprazolam treatment.
    Curtis GC; Abelson JL; Gold PW
    Biol Psychiatry; 1997 Jan; 41(1):76-85. PubMed ID: 8988798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortisol as an indicator of hypothalmic-pitituary-adrenal axis dysregulation in patients with panic disorder: a literature review.
    Jakuszkowiak-Wojten K; Landowski J; Wiglusz MS; Cubała WJ
    Psychiatr Danub; 2015 Sep; 27 Suppl 1():S445-51. PubMed ID: 26417813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of specific association between panicogenic properties of caffeine and HPA-axis activation. A placebo-controlled study of caffeine challenge in patients with panic disorder.
    Masdrakis VG; Markianos M; Oulis P
    Psychiatry Res; 2015 Sep; 229(1-2):75-81. PubMed ID: 26243374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder.
    Petrowski K; Wintermann GB; Kirschbaum C; Bornstein SR
    Psychoneuroendocrinology; 2012 Aug; 37(8):1199-208. PubMed ID: 22277728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A striking pattern of cortisol non-responsiveness to psychosocial stress in patients with panic disorder with concurrent normal cortisol awakening responses.
    Petrowski K; Herold U; Joraschky P; Wittchen HU; Kirschbaum C
    Psychoneuroendocrinology; 2010 Apr; 35(3):414-21. PubMed ID: 19913360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CO2 challenge results in hypothalamic-pituitary-adrenal activation in healthy volunteers.
    van Duinen MA; Schruers KR; Maes M; Griez EJ
    J Psychopharmacol; 2005 May; 19(3):243-7. PubMed ID: 15888509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimentally challenged reactivity of the hypothalamic pituitary adrenal axis in patients with recently diagnosed rheumatoid arthritis.
    Dekkers JC; Geenen R; Godaert GL; Glaudemans KA; Lafeber FP; van Doornen LJ; Bijlsma JW
    J Rheumatol; 2001 Jul; 28(7):1496-504. PubMed ID: 11469453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Panic induced by carbon dioxide inhalation and lack of hypothalamic-pituitary-adrenal axis activation.
    Sinha SS; Coplan JD; Pine DS; Martinez JA; Klein DF; Gorman JM
    Psychiatry Res; 1999 May; 86(2):93-8. PubMed ID: 10397411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary cortisol in panic: are males more vulnerable?
    van Duinen MA; Schruers KR; Jaegers E; Maes M; Griez EJ
    Neuro Endocrinol Lett; 2004 Oct; 25(5):386-90. PubMed ID: 15580175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the hypothalamic-pituitary-adrenocortical system in patients with panic disorder.
    Erhardt A; Ising M; Unschuld PG; Kern N; Lucae S; Pütz B; Uhr M; Binder EB; Holsboer F; Keck ME
    Neuropsychopharmacology; 2006 Nov; 31(11):2515-22. PubMed ID: 16841071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of basal pituitary-adrenal overactivity in first episode, drug naïve patients with schizophrenia.
    Ryan MC; Sharifi N; Condren R; Thakore JH
    Psychoneuroendocrinology; 2004 Sep; 29(8):1065-70. PubMed ID: 15219658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study.
    Zwanzger P; Eser D; Aicher S; Schüle C; Baghai TC; Padberg F; Ella R; Möller HJ; Rupprecht R
    Neuropsychopharmacology; 2003 May; 28(5):979-84. PubMed ID: 12700707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term basal and dynamic evaluation of hypothalamic-pituitary-adrenal (HPA) axis in acromegalic patients.
    Ronchi CL; Ferrante E; Rizzo E; Giavoli C; Verrua E; Bergamaschi S; Lania AG; Beck-Peccoz P; Spada A
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):608-12. PubMed ID: 18410544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 24-hour pituitary and adrenal hormone profiles in chronic fatigue syndrome.
    Di Giorgio A; Hudson M; Jerjes W; Cleare AJ
    Psychosom Med; 2005; 67(3):433-40. PubMed ID: 15911907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acute effects of a mineralocorticoid receptor (MR) agonist on nocturnal hypothalamic-adrenal-pituitary (HPA) axis activity in healthy controls.
    Buckley TM; Mullen BC; Schatzberg AF
    Psychoneuroendocrinology; 2007; 32(8-10):859-64. PubMed ID: 17666187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.